Literature DB >> 23720164

Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy.

Margaret S Soper1, Shawn Iganej, Lester D R Thompson.   

Abstract

BACKGROUND: Salivary duct carcinoma (SDC) is an aggressive malignancy with high recurrence rates. Standard management includes surgical resection followed by adjuvant radiation. Androgen receptor positivity has been described to be present in 40% to 90% of SDCs, and a recent case series showed a benefit to androgen deprivation therapy (ADT) in recurrent or metastatic disease. METHODS AND
RESULTS: We present the case of an 87-year-old woman with a locally advanced androgen receptor-positive parotid SDC treated definitively with ADT and external beam radiotherapy, a regimen modeled after the treatment of prostate cancer. She had a complete response on positron emission tomography (PET)/CT scan and had no evidence of disease 24 months after the completion of treatment.
CONCLUSION: To our knowledge, this case report is the first to describe the use of ADT plus radiation to definitively treat SDC. This regimen could be considered in patients with androgen receptor-positive SDCs who are considered unresectable or who refuse surgery.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  androgen deprivation therapy; androgen receptor; radiation; salivary duct carcinoma; salivary gland

Mesh:

Substances:

Year:  2013        PMID: 23720164     DOI: 10.1002/hed.23383

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  16 in total

1.  Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.

Authors:  Yang Ni; Francesco C Stingo; Min Jin Ha; Rehan Akbani; Veerabhadran Baladandayuthapani
Journal:  J Am Stat Assoc       Date:  2018-08-15       Impact factor: 5.033

2.  Androgen deprivation therapy for metastatic salivary gland cancer.

Authors:  Arielle Elkrief; Ramy Saleh
Journal:  CMAJ       Date:  2018-08-20       Impact factor: 8.262

Review 3.  Genetic alterations in salivary gland cancers.

Authors:  Linda X Yin; Patrick K Ha
Journal:  Cancer       Date:  2016-02-29       Impact factor: 6.860

4.  Molecular patterns in salivary duct carcinoma identify prognostic subgroups.

Authors:  Ruta Gupta; Mark J Cowley; Simon A Mueller; Marie-Emilie A Gauthier; James Blackburn; John P Grady; Spiridoula Kraitsek; Elektra Hajdu; Matthias S Dettmer; Jane E Dahlstrom; C Soon Lee; Peter P Luk; Bing Yu; Roland Giger; Sarah Kummerfeld; Jonathan R Clark
Journal:  Mod Pathol       Date:  2020-05-26       Impact factor: 7.842

5.  Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors.

Authors:  Nhu Thuy Can; Mark W Lingen; Heather Mashek; James McElherne; Renee Briese; Carrie Fitzpatrick; Annemieke van Zante; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2017-07-05

6.  An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.

Authors:  Randall T Butler; Matthew E Spector; Dafydd Thomas; Andrew S McDaniel; Jonathan B McHugh
Journal:  Head Neck Pathol       Date:  2013-09-25

Review 7.  Biological roles and clinical significance of estrogen and androgen receptors in head and neck cancers.

Authors:  Chunhong Qin; Yan Lu; Huimin Zhang; Zhe Zhang; Wei Xu; Shuxin Wen; Wei Gao; Yongyan Wu
Journal:  J Cancer       Date:  2022-04-04       Impact factor: 4.478

8.  Androgen-Receptor Positive Lacrimal Sac Adenocarcinoma Demonstrating Long-Lasting Response to LHRH Analog Plus Abiraterone Treatment.

Authors:  Elena Vagia; Panagiota Economopoulou; Nikolaos Oikonomopoulos; Ilias Athanasiadis; George Dimitriadis; Amanda Psyrri
Journal:  Front Oncol       Date:  2015-02-02       Impact factor: 6.244

Review 9.  AR-Signaling in Human Malignancies: Prostate Cancer and Beyond.

Authors:  Michael T Schweizer; Evan Y Yu
Journal:  Cancers (Basel)       Date:  2017-01-11       Impact factor: 6.639

10.  Androgen Deprivation Therapy for Patients with Androgen-Receptor-Positive Metastatic Salivary Duct Carcinoma: A Case Report and Review of the Literature.

Authors:  Yongfei You; Panpan Wang; Xi Wan; Liping Xu; Yi Gong; Weihua Zhang
Journal:  Onco Targets Ther       Date:  2021-05-28       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.